Are Options Traders Betting on a Big Move in Hepion (HEPA) Stock?Zacks Investment Research • 12/09/20
Hepion Pharmaceuticals: CRV431 Continues To Progress In Early Phase NASH Clinical TrialsSeeking Alpha • 06/30/20
Hepion Pharmaceuticals And Neoleukin Therapeutics: Two Micro Cap Pharmaceutical Stocks Priced For "Non Success" With Promising DrugsSeeking Alpha • 11/26/19
Hepion Pharmaceuticals And Neoleukin Therapeutics: 2 Micro-Cap Pharmaceutical Stocks Priced For 'Non Success' With Promising DrugsSeeking Alpha • 11/26/19
Hepion Pharmaceuticals' stock rockets after upbeat results of preclinical study of liver cirrhosis treatmentMarket Watch • 11/21/19
Hepion Pharmaceuticals stock soars premarket-leading volume after positive data on liver disease treatmentMarket Watch • 10/17/19